Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
CV Sciences ( (CVSI) ) has provided an announcement.
CV Sciences, Inc. is set to acquire Extract Labs, a prominent cannabinoid product manufacturer, in a strategic move to boost revenue and customer base while optimizing operations. The acquisition, expected to close in early 2025, involves a $400,000 cash payment and $1,000,000 in company stock, with potential earnouts based on Extract Labs’ revenue performance. This deal aims to enhance CV Sciences’ production capabilities, control over supply chain, and accelerate new product development, thereby driving long-term growth and shareholder value.
See more data about CVSI stock on TipRanks’ Stock Analysis page.
Trending Articles
- Nvidia Stock Could Take a Beating from Supply Snags on Blackwell Chips
- ‘This Is Just Pure Hype,’ Says Top Investor About Tesla Stock
- Will Palantir Stock Crash to $28? Jefferies Sounds the Alarm
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
